| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |